XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.23.2

Net Loss Per Share | 6 Months Ended
--- | ---
Jun. 30, 2023
Earnings Per Share [Abstract] |
Net Loss Per Share | Net Loss Per Share A reconciliation of net loss available to common stockholders and the number of shares in the calculation of basic and diluted loss per share is as follows:
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2023 |  | 2022 |  | 2023 |  | 2022
Net loss |  | $ | (18,697) |  |  | $ | (11,552) |  |  | $ | (37,419) |  |  | $ | (23,360) |
Weighted-average shares used in computing net loss per share, basic and diluted |  | 44,278,427 |  |  | 13,446,622 |  |  | 44,175,274 |  |  | 8,336,451 |
Net loss per share attributable to common stockholders, basic and diluted |  | $ | (0.42) |  |  | $ | (0.86) |  |  | $ | (0.85) |  |  | $ | (2.80) |
The following potential common stock securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (on an as-converted basis):
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2023 |  | 2022 |  | 2023 |  | 2022
Stock options to purchase common stock |  | 12,056,731 |  | 8,779,368 |  | 12,056,731 |  | 8,779,368
Unvested early exercised options |  | 80,180 |  | 288,807 |  | 80,180 |  | 288,807
Restricted stock units outstanding |  | 335,884 |  |  | — |  |  | 335,884 |  |  | — |
Contingent earnout common stock |  | 2,000,000 |  |  | 2,000,000 |  |  | 2,000,000 |  |  | 2,000,000 |
Total |  | 14,472,795 |  | 11,068,175 |  | 14,472,795 |  | 11,068,175
The potential common stock securities above do not reflect 19,633,444 of potentially dilutive securities as a result of the option issued to GeneFab, as announced on August 10, 2023. Refer to Note 13, Subsequent Events, for further details of the GeneFab transaction.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration